Name: Neurogene Inc. (NGNE) Financial Statements
Creator: FinSpry

Neurogene Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Neurogene Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Revenue & Gross Profit
Revenue	0.93	0.00	0.00	0.00
Cost of Revenue	60.82	44.39	47.51	42.26
Gross Profit	-59.89	-44.39	-47.51	-42.26
Operating Expenses
Research & Development	60.92	44.39	47.51	42.26
Selling, General & Administrative	22.61	11.19	9.01	8.27
Operating Expenses	22.61	11.19	56.52	8.27
Operating Income	-82.51	-55.58	-56.52	-50.53
Other Income/Expense
Interest Income	8.47	2.95	1.34	0.02
Interest Expense	-0.01	-0.01	0.00	0.00
Other Income/Expense	-0.99	-0.03	-0.01	0.00
Income
Income Before Tax	-75.14	-36.32	-55.19	-50.52
Income Tax Expense	0.00	0.00	0.00	0.00
Net Income	-75.14	-36.32	-55.19	-50.52
Net Income - Continuous Operations	-75.14	-36.32	-55.19	-50.52
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00
EBITDA	-79.26	-52.29	-51.99	-49.59
EBIT	-82.51	-55.58	-55.19	-50.53
Depreciation & Amortization	3.25	3.30	3.20	0.95
Earnings Per Share
Basic EPS	-4.00	28.00	-38.00	-12.00
Diluted EPS	-4.00	3.00	-38.00	-12.00
Basic Shares Outstanding	17.57	0.49	1.46	4.05
Diluted Shares Outstanding	17.57	4.66	1.46	4.05